Literature DB >> 15800785

Primary effusion lymphoma: successful treatment with highly active antiretroviral therapy and rituximab.

Soon Thye Lim, Nancy Rubin, Jonathan Said, Alexandra M Levine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15800785     DOI： 10.1007/s00277-005-1040-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  14 in total

Review 1.  Current status of treatment for primary effusion lymphoma.

Authors:  Seiji Okada; Hiroki Goto; Mihoko Yotsumoto
Journal:  Intractable Rare Dis Res       Date:  2014-08

Review 2.  Management of patients with HIV in the intensive care unit.

Authors:  Henry Masur
Journal:  Proc Am Thorac Soc       Date:  2006

Review 3.  Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.

Authors:  William R Foster; Alina Bischin; Russell Dorer; David M Aboulafia
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-04-01

4.  Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma.

Authors:  Z Qin; L Dai; M Bratoeva; M G Slomiany; B P Toole; C Parsons
Journal:  Leukemia       Date:  2011-06-10       Impact factor: 11.528

Review 5.  Plasmid Partitioning by Human Tumor Viruses.

Authors:  Ya-Fang Chiu; Bill Sugden
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

6.  Elotuzumab, a potential therapeutic humanized anti-SLAMF7 monoclonal antibody, enhances natural killer cell-mediated killing of primary effusion lymphoma cells.

Authors:  Jutatip Panaampon; Ryusho Kariya; Seiji Okada
Journal:  Cancer Immunol Immunother       Date:  2022-03-09       Impact factor: 6.630

Review 7.  New approaches to the treatment of human herpesvirus 8-associated disease.

Authors:  Corey Casper
Journal:  Rev Med Virol       Date:  2008 Sep-Oct       Impact factor: 6.989

8.  Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.

Authors:  Zhiqiang Qin; Lu Dai; Jimena Trillo-Tinoco; Can Senkal; Wenxue Wang; Tom Reske; Karlie Bonstaff; Luis Del Valle; Paulo Rodriguez; Erik Flemington; Christina Voelkel-Johnson; Charles D Smith; Besim Ogretmen; Chris Parsons
Journal:  Mol Cancer Ther       Date:  2013-10-18       Impact factor: 6.261

9.  Primary effusion lymphoma diagnosed by pericardiocentesis.

Authors:  Michael C Nemunaitis; Jeffrey M Schussler; S Michelle Shiller; Louis M Sloan; Robert G Mennel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-01

10.  Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.

Authors:  Dirk P Dittmer; Kristy L Richards; Blossom Damania
Journal:  Front Microbiol       Date:  2012-04-18       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.